Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Anemia

  Free Subscription


Articles published in JAMA

Retrieve available abstracts of 20 articles:
HTML format



Single Articles


    October 2021
  1. ABOU BAKER NM, Davis AM
    Gastrointestinal Evaluation of Iron Deficiency Anemia.
    JAMA. 2021;326:1624-1625.
    PubMed    


    September 2021
  2. KENTER MJH, Cohen AF
    Poloxamer 188 vs Placebo for Painful Vaso-occlusive Episodes in Children and Adults With Sickle Cell Disease.
    JAMA. 2021;326:974-975.
    PubMed    


  3. GURKAN UA
    Poloxamer 188 vs Placebo for Painful Vaso-occlusive Episodes in Children and Adults With Sickle Cell Disease.
    JAMA. 2021;326:975.
    PubMed    


  4. CASELLA JF, Kronsberg SS, Gorney RT
    Poloxamer 188 vs Placebo for Painful Vaso-occlusive Episodes in Children and Adults With Sickle Cell Disease-Reply.
    JAMA. 2021;326:975-976.
    PubMed    


    July 2021
  5. ZHANG H, Kilaru AS, Meisel ZF, Bao Y, et al
    Prescription Drug Monitoring Program Mandates and Opioids Dispensed Following Emergency Department Encounters for Patients With Sickle Cell Disease or Cancer With Bone Metastasis.
    JAMA. 2021;326:274-276.
    PubMed    


    June 2021
  6. SATO T, Terada R, Ikeda T
    Effect of Restrictive or Liberal Blood Transfusion on Major Cardiovascular Events in Patients With Acute Myocardial Infarction and Anemia.
    JAMA. 2021;325:2505-2506.
    PubMed    


  7. DUCROCQ G, Simon T, Steg PG
    Effect of Restrictive or Liberal Blood Transfusion on Major Cardiovascular Events in Patients With Acute Myocardial Infarction and Anemia-Reply.
    JAMA. 2021;325:2506-2507.
    PubMed    


    May 2021

  8. Foreign Letters: London.
    JAMA. 2021;325:1907.
    PubMed    


    April 2021
  9. ZYLKE J
    Poloxamer 188 for Sickle Cell Disease.
    JAMA. 2021;325:1524.
    PubMed    


  10. CASELLA JF, Barton BA, Kanter J, Black LV, et al
    Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial.
    JAMA. 2021;325:1513-1523.
    PubMed     Abstract available


  11. EHRENREICH H, Neubauer AP, Miskowiak K
    Effect of Early Recombinant Human Erythropoietin on Neurodevelopmental Outcomes at Age 5 Years.
    JAMA. 2021;325:1470-1471.
    PubMed    


  12. NATALUCCI G, Bucher HU, Fauchere JC
    Effect of Early Recombinant Human Erythropoietin on Neurodevelopmental Outcomes at Age 5 Years-Reply.
    JAMA. 2021;325:1471-1472.
    PubMed    


    February 2021
  13. DUCROCQ G, Gonzalez-Juanatey JR, Puymirat E, Lemesle G, et al
    Effect of a Restrictive vs Liberal Blood Transfusion Strategy on Major Cardiovascular Events Among Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Clinical Trial.
    JAMA. 2021;325:552-560.
    PubMed     Abstract available


    January 2021
  14. ABBASI J
    Promising Strategies for Sickle Cell Disease and beta-Thalassemia.
    JAMA. 2021;325:121.
    PubMed    


    December 2020
  15. NATALUCCI G, Latal B, Koller B, Ruegger C, et al
    Neurodevelopmental Outcomes at Age 5 Years After Prophylactic Early High-Dose Recombinant Human Erythropoietin for Neuroprotection in Very Preterm Infants.
    JAMA. 2020;324:2324-2327.
    PubMed    


    February 2020
  16. WOLF M, Rubin J, Achebe M, Econs MJ, et al
    Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials.
    JAMA. 2020;323:432-443.
    PubMed     Abstract available


    January 2020
  17. MURALI SB
    Treatment of Iron Deficiency After Gastric Bypass-Reply.
    JAMA. 2020;323:377.
    PubMed    


  18. AUERBACH M
    Treatment of Iron Deficiency After Gastric Bypass.
    JAMA. 2020;323:376-377.
    PubMed    


    December 2019
  19. SANCAR F
    New Therapy for Rare Anemia.
    JAMA. 2019;322:2277.
    PubMed    


  20. ABBASI J
    Study Evaluates Rapid Sickle Cell Disease Test.
    JAMA. 2019;322:2161.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: